Abicon Tablet

Presentation: Abicon tablets are typically available in blister packs. The exact composition may vary depending on the manufacturer. One common formulation of Abicon tablets contains Nalidixic Acid BP 300 mg and Metronidazole BP 200 mg. Another formulation contains Sodium Alginate USP 500 mg and Potassium Bicarbonate BP 100 mg or Sodium Alginate USP and Calcium Carbonate. Always check the product packaging for the specific active ingredients and their strengths.

• Note: Given the varying compositions under the brand name "Abicon", the description below will cover the Nalidixic Acid and Metronidazole formulation, as this is a commonly referenced combination. If you are referring to a different Abicon product, please specify the active ingredients.

Indications (for Nalidixic Acid and Metronidazole combination): Abicon (Nalidixic Acid and Metronidazole) is indicated for the treatment of certain bacterial and parasitic infections, such as:

• Diarrhoea
• Dysentery

Dosage and Administration (for Nalidixic Acid and Metronidazole combination): The dosage and duration of treatment with Abicon depend on the type and severity of the infection, as well as the patient's age and weight. It should be taken orally as directed by a physician, usually with food.

• Adults: The usual dose is one tablet two to three times daily. The duration of treatment is usually 5-10 days.
• Children: Dosage is usually calculated based on body weight and should be determined by a physician.

Swallow the tablet whole with water. Do not chew, crush, or break it. Complete the full course of treatment even if you feel better.

Side Effects (for Nalidixic Acid and Metronidazole combination): Common side effects of Abicon may include:

• Nausea
• Vomiting
• Stomach pain
• Loss of appetite
• Headache
• Dry mouth
• Metallic taste

Less common side effects may include dizziness, drowsiness, and skin rash. Consumption of alcohol should be avoided during and for at least 48 hours after treatment with Metronidazole due to the possibility of a disulfiram-like reaction.

Precautions (for Nalidixic Acid and Metronidazole combination): Abicon is contraindicated in patients with known hypersensitivity to Nalidixic Acid, Metronidazole, or other nitroimidazole or quinolone derivatives.

Caution should be exercised in patients with:

• Central nervous system disorders (e.g., epilepsy).
• Severe liver or kidney disease.
• Blood disorders.

Inform your doctor about all other medications you are taking, as Nalidixic Acid and Metronidazole can interact with certain drugs. The use of this combination during pregnancy, especially the first trimester, and during breastfeeding is generally not recommended and should only be considered if clearly necessary and under medical supervision.

Storage: Store Abicon tablets below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.